Treatment considerations in the management of age-related osteoporosis.
Rubin
C D
CD
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8889, USA. crubin@mednet.swmed.edu
D000367:Age Factors; D000368:Aged; D015519:Bone Density; D002116:Calcitonin / Q000627:therapeutic use; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000819:agonists; D005260:Female; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy*; D015663:Osteoporosis, Postmenopausal / Q000628:therapy; D010880:Piperidines / Q000627:therapeutic use; D020849:Raloxifene Hydrochloride; D012306:Risk; D012307:Risk Factors; D012720:Severity of Illness Index
D004164:Diphosphonates; D004967:Estrogens; D010880:Piperidines; D020849:Raloxifene Hydrochloride; D002116:Calcitonin; D002118:Calcium